Aspirin

EH Awtry, J Loscalzo - Circulation, 2000 - Am Heart Assoc
elaboration. Aspirin can also directly scavenge hydroxyl radicals to form the 2, 3-and 2, 5-
dihydroxybenzoate derivatives, which themselves serve as markers of oxidative stress25 …

Peri-procedural myocardial injury: 2005 update

J Herrmann - European heart journal, 2005 - academic.oup.com
During the past three decades, percutaneous coronary intervention has become one of the
cardinal treatment strategies for stenotic coronary artery disease. Technical advances …

Peri-operative management of antiplatelet therapy in patients with coronary artery disease

W Korte, M Cattaneo, PG Chassot… - Thrombosis and …, 2011 - thieme-connect.com
An increasing number of patients suffering from cardiovascular disease, especially coronary
artery disease (CAD), are treated with aspirin and/or clopidogrel for the prevention of major …

A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with …

L Polonski, M Gasior, M Gierlotka, T Osadnik… - International journal of …, 2011 - Elsevier
BACKGROUND: Prognoses in STEMI and NSTEMI beyond one year from onset remain
unclear. We aimed to compare the treatments and the two-year outcomes in patients with …

Benefits, challenges, and registerability of the polypill

P Sleight, H Pouleur, F Zannad - European heart journal, 2006 - academic.oup.com
Guidelines for the management of cardiovascular disease (CVD) stress the importance of
treating global risk, rather than individual risk, factors. Patients at high cardiovascular (CV) …

Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

KL Tsai, PL Hsieh, WC Chou, HC Cheng, YT Huang… - Cell & Bioscience, 2021 - Springer
Background Emerging evidence demonstrated dapagliflozin (DAPA), a sodium-glucose
cotransporter 2 inhibitor, prevented various cardiovascular events. However, the detailed …

[HTML][HTML] Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data …

S Mangiapane, R Busse - Deutsches Ärzteblatt International, 2011 - ncbi.nlm.nih.gov
Background Current guidelines recommend using aspirin, clopidogrel, beta-blockers,
statins, and angiotensin converting enzyme (ACE) inhibitors after acute myocardial infarction …

[PDF][PDF] The association between aspirin and blood loss in hip fracture patients

MT Kennedy, S Roche, SM Fleming… - Acta orthopaedica …, 2006 - researchgate.net
Fifty one percent of patients had extracapsular hip fractures, and these patients were
comparable in terms of demographic characteristics, including aspirin use, to the group with …

[HTML][HTML] Поражения желудка и двенадцатиперстной кишки у больных с острым коронарным синдромом

АЛ Верткин, ОВ Зайратьянц, ЕИ Вовк - Лечащий врач, 2006 - lvrach.ru
В России и других странах Европы болезни сердечно-сосудистой системы занимают
первое место среди причин заболеваемости и смертности населения. Так, в 2002 г …

[HTML][HTML] Clinical disease registries in acute myocardial infarction

R Ashrafi, H Hussain, R Brisk, L Boardman… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Disease registries, containing systematic records of cases, have for nearly 100 years been
valuable in exploring and understanding various aspects of cardiology. This is particularly …